Millstone Evans Group, LLC Novavax Inc Transaction History
Millstone Evans Group, LLC
- $147 Billion
- Q1 2025
A detailed history of Millstone Evans Group, LLC transactions in Novavax Inc stock. As of the latest transaction made, Millstone Evans Group, LLC holds 400 shares of NVAX stock, worth $2,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$2,564
Previous $3.22 Million
20.27%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
299Shares Held
90MCall Options Held
5.76MPut Options Held
6.65M-
Vanguard Group Inc Valley Forge, PA15.7MShares$100 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$75.9 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$71.4 Million33.15% of portfolio
-
State Street Corp Boston, MA7.04MShares$45.1 Million0.0% of portfolio
-
Coatue Management LLC New York, NY3.84MShares$24.6 Million0.13% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $501M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...